Next year’s conference is scheduled for November 13 to 17, 2015, in Las Vegas, NV.
After the deal was announced, Valeant abandoned its lengthy takeover attempt.
The Actavis CEO said he expects annual revenues to reach $23 billion in 2015.
Nearly 900 industry leaders attended this year’s forum ahead of the AAO meeting.
Google team member appeals to ophthalmic community to offer ideas for how miniature technology may be used in future eye care.
The lens is the first combination multifocal toric IOL to be considered for approval in the US.
Implantation of the Glaukos iStent continued to lead the procedure volume increase during the quarter.
US IVT injection volume grew 3.7 percent year over year.
Market Scope expects this complex treatment market to grow at a healthy rate through 2019.
On the eve of Veterans Day, the new secretary announced a major restructuring of his department’s health care system.
You are not currently logged in.
©2017 Market Scope
Lost your Password